Balance sheet of Jubilant Pharmova is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Jubilant Pharmova is increasing.
Latest debt of Jubilant Pharmova is ₹1,748 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹1,502 Crs.

Yes, profit is increasing.
The profit of Jubilant Pharmova is ₹620 Crs for TTM, ₹77.1 Crs for Mar 2024 and -₹61 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Jubilant Pharmova latest dividend payout ratio is 102.46% and 3yr average dividend payout ratio is 60.85%

Companies resources are majorly tied in miscellaneous assets